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Langerhans Cells Integrated into Human Reconstructed
Epidermis Respond to Known Sensitizers and Ultraviolet
Exposure
To the Editor:
In 1997, we reported the first successful integration of
human epidermal Langerhans cells into a reconstructed
human epidermis (Re´gnier et al, 1997). All experiments were
conducted with the proper institutional approval. After
considerable effort, we succeeded in transferring the initial
protocol to an epidermal model that has the potential to be
produced at an industrial level. Within the epidermis,
reconstructed on the collagenic Episkin dermal support,
the CD34þ -derived dendritic Langerhans cells are located
in the suprabasal cell layers at a density (30,000 cells per
cm2) comparable to that of normal human skin (Schempp
et al, 2000). Advantageously to skin organ cultures, where
Langerhans cells emigrate spontaneously from the epider-
mis (Larsen et al, 1990), they remained resident cells. As in
the initial model, the integrated Langerhans cells exhibit all
characteristic features of epidermal Langerhans cells such
as Birbeck granules and CD1a surface antigens (Re´gnier
et al, 1997).
In vivo, capture of low-molecular-weight allergens bound
to epidermal proteins induces activation and migration of
epidermal Langerhans cells to the regional lymph nodes
where they present the processed antigen to naı¨ve T cells
(sensitization phase). This phase is characterized by
morphologic, phenotypic, and functional modifications of
the Langerhans cells, e.g., the upregulation of costimulatory
molecules such as CD86 at their surface.
Several reports have described how ultraviolet (UV)
exposure of the skin induces a phenomenon generally
described as immunosuppression implicating directly the
epidermal Langerhans cells (Kripke and Morison, 1985;
Ullrich, 1995; Kelly et al, 1998). Immunosuppression after
UV exposure is characterized by a reduction in the number
of epidermal Langerhans cells, an alteration of their
morphology, and a depletion of certain cell surface markers
(Aberer et al, 1981; Bacci et al, 1998).
To assess the reactivity of the integrated Langerhans
cells and to compare it to their in vivo response, we
exposed the reconstructed epidermis to some known
allergens, the irritant SLS, and solar simulated irradiation.
Reconstruction of the human epidermis containing
Langerhans cells was achieved by co-seeding CD34þ -
derived dendritic cells (5  104 CD1aþ ) with 4  105
heterologous keratinocytes onto the Episkin support (1.3
cm2). Cells were submerged for 3 d in Dulbecco’s modified
Eagle’s medium/Ham F12 (3:1), containing 10% fetal bovine
serum, 10 ng per mL epidermal growth factor, 400 ng per
mL hydrocortisone, 106 M isoproterenol, 5 mg per mL
transferrin, 2  109 M triiodothyronine, 1.8  104 M
adenine, and 5 mg per mL insulin. To induce epidermal
differentiation, the reconstructs were put for 10 d at the air–
liquid interface in culture medium without isoproterenol,
transferrin, triiodothyronine, and adenine.
As shown in Fig 1, the human reconstructed epidermis
on the Episkin support (Fig 1a) exhibits a well-stratified
epidermis with Langerhans cells located in its suprabasal
layers (Fig 1b). Immunostaining of the Langerhans cells in
the respective epidermal sheet reveals a dense network of
equally distributed Langerhans cells (Fig 1c). As reported
earlier for the reconstructed epidermis on de-epidermized
epidermis (Re´gnier et al, 1997), Langerhans cells do not
emigrate spontaneously from the epidermis as reported in
cultured skin explants (Larsen et al, 1990).
Exposure of the reconstructed skin to the known
sensitizers dinitrofluorobenzene, NiSO4, the irritant SLS,
and solar simulated irradiation (Fig 2) affects the integrated
Langerhans cells in a similar way as described for their in
vivo counterparts. Topically applied sensitizers dinitrofluor-
obenzene and NiSO4 (Fig 2b,c) induced a reduction in the
number of Langerhans cells and affected their characteristic
dendritic morphology, whereas the irritant SLS induced no
visible changes, (Fig 2d) confirming the observations made
by Aiba et al (1997) that dendritic cells respond differently
to haptens and irritants. The same holds true for the
upregulation of the surface antigen CD86 (Aiba et al, 2000)
observed in the reconstructed epidermis after exposure to
haptens (results not shown). In a separate set of experi-
ments (not shown) we ensured that the upregulation of
CD86 is specific for the integrated Langerhans cells, as
keratinocytes do not express CD86 under our experimental
conditions.
The most dramatic changes were observed after
exposure of the reconstruct to solar simulated irradiation.
A dose of 8.4 J per cm2 solar simulated irradiation,
equivalent to a sun exposure of about 1 h, induced not
only a remarkable reduction in the number of langerin-
positive cells, but also changed the morphology of the
remaining Langerhans cells from a dendritic to a round cell
type (Fig 2e). These UV-induced changes resemble very
much those observed in vivo (Cooper et al, 1992; Neale
et al, 1997), which are described to be closely related to UV-
induced immunosuppression (Kelly et al, 1998). Interest-
ingly, application of a broad-spectrum sunscreen before
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irradiation afforded, as already described in vivo (Dumay
et al, 2001; Moyal and Fourtanier, 2001), complete protec-
tion of the Langerhans cells (Fig 2f ).
In conclusion, the above-described results, even though
preliminary and incomplete, clearly show that the reactivity
of the Langerhans cells integrated into a reconstructed
epidermis is comparable to in vivo. Beside its potential to be
produced at an industrial level and to serve some day as an
alternative model for estimating the sensitizing potential of
new chemicals, it also provides an excellent research tool to
study Langerhans cell biology in vitro. This letter is also
intended as an invitation for laboratories specialized in the
field of immunology, in particular that of the skin, to use and
further validate this model by generating new results and
insights into epidermal Langerhans cell physiology.
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